Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Back

IMI
Rapid-Fire Poster Talk

RFPT05--Detection & Diagnosis of Infection

Thursday, September 26, 2024
1:30 PM – 2:20 PM ET
Location:Theater B (Exhibit & Poster Hall)

Presenters will be given the opportunity to succinctly present the essence of their poster data one after another. After the session, questions can be addressed with the presenter by visiting their poster during the open Poster Hall hours.

Learning Objectives:

  • Review the current landscape of detection and diagnosis of infection with widespread of ETI.
  • Discuss novel techniques and assays for infection detection
  • Evaluate microbial dynamics in response to ant-infectives and pulmonary therapies

Presentations:

  • 1:30 PM – 2:20 PM ET
    RFPT05.1- Diagnostic target product profiles for managing infections and exacerbations in cystic fibrosis

    Speaker: Rebecca Holmes (she/her/hers) – LifeArc

  • 1:30 PM – 2:20 PM ET
    RFPT05.3- Exploring multiple sampling techniques to characterise the airway microbiota in people with CF (pwCF) on ETI (elexacaftor/tezacaftor/ivacaftor) and a history of P. aeruginosa (PA) colonisation

    Speaker: Kevin F. Deasy, BSc, MB, MRCPI – Cork University Hospital

  • 1:30 PM – 2:20 PM ET
    RFPT05.4- Thinking outside the ‘Sputum Box’

    Speaker: Simone Hadjisymeou Andreou – Royal Brompton Hospital/ NHLI/ Imperial college

  • 1:30 PM – 2:20 PM ET
    RFPT05.5- Reliability of clinic-obtained versus self-obtained respiratory samples from the Self-Sample Accuracy and Benefit Implementation Trial (S2wAB-IT)

    Speaker: Jordana Hoppe, MD (she/her/hers) – University of Colorado

  • 1:30 PM – 2:20 PM ET
    RFPT05.6- A Prospective Standardized Assessment of People with CF and Non-tuberculosis Mycobacteria Pulmonary Disease Undergoing Treatment with Bacteriophage: Design and Initial Results of the POSTSTAMP Study

    Speaker: Jerry A. Nick, MD (he/him/his) – National Jewish Health

  • 1:30 PM – 2:20 PM ET
    RFPT05.7- Detection of Pseudomonas aeruginosa transcripts in the nasal metatranscriptome of people with cystic fibrosis

    Speaker: Thaddeus R. Cybulski, MD, PhD (he/him/his) – Northwestern Feinberg School of Medicine

  • 1:30 PM – 2:20 PM ET
    RFPT05.8- Persistence and evolution of opportunistic pathogens in the homes of people with cystic fibrosis

    Speaker: Catherine R. Armbruster, PhD MPH – Carnegie Mellon University